INVST’s Langar Global HealthTech ETF LGHT Stock Holding History

INVST’s Portfolio LGHT Stock Details LGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$639K	Buy	74,808 +3,098	+4%	+$26K	0.06%	234
2026 Q1	$624K	Buy	71,710 +4,019	+6%	+$38.6K	0.07%	234
2025 Q4	$677K	Buy	67,691 +2,683	+4%	+$27.2K	0.07%	216
2025 Q3	$654K	Buy	65,008 +2,348	+4%	+$24.2K	0.07%	221
2025 Q2	$653K	Buy	62,660 +11,228	+22%	+$111K	0.08%	206
2025 Q1	$504K	Buy	51,432 +34,754	+208%	+$367K	0.07%	217
2024 Q4	$170K	Buy	+16,678	New	+$175K	0.02%	241

Other funds holding LGHT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

INVST's LGHT Position: Q2 2026 in Review

INVST increased its Langar Global HealthTech ETF (LGHT) stake by 4.3% in Q2 2026, buying an estimated $26K and bringing the position to 74,808 shares worth $639K. The position accounts for 0.06% of the portfolio, ranked #234.

INVST first reported a position in LGHT in Q4 2024 and has held it in 7 quarters since. The position peaked at $677K in Q4 2025. 3 funds tracked by Wall St. Rank hold LGHT as of Q2 2026.

INVST held 74,808 shares of Langar Global HealthTech ETF worth $639K as of Q2 2026.
INVST bought 3,098 Langar Global HealthTech ETF shares in Q2 2026, an estimated $26K.
Langar Global HealthTech ETF made up 0.06% of INVST's portfolio in Q2 2026, its #234 holding.
INVST first reported a position in Langar Global HealthTech ETF in Q4 2024 and has held it in 7 quarters since.
INVST's Langar Global HealthTech ETF position peaked at $677K in Q4 2025.
3 funds tracked by Wall St. Rank held Langar Global HealthTech ETF as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.